Buprenorphine Cost Effectiveness

ePAPER READ

DOWNLOAD ePAPER

buprenorphine.samhsa.gov

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

START NOW

Preliminary cost-effectiveness results to<br />

be presented at meeting

Financing Buprenorphine in the Treatment of Opioid Addiction

Diversion and Abuse of Buprenorphine: A Brief Assessment of ...

Physician Clinical Support System ? Buprenorphine (PCSS-B)

You're invited to attend A One Day Educational ... - Buprenorphine

Use of Buprenorphine in the Pharmacologic Management of Opioid ...

Evaluation of the Buprenorphine Waiver Program: Study Overview

RADARS System Subutex & Suboxone: How Much ... - Buprenorphine

MAPS, Michigan Automated Prescription System - Buprenorphine

Nurse Care Manager Model - Buprenorphine

Buprenorphine In The Treatment Of Opioid Addiction

statement of rights acknowledgment and consent - Buprenorphine

Preliminary cost-effectiveness results to be presented at meeting

Limitations • Cohort treated at a single site • Drug use out of treatment was not observed, we assume 89% return to drug use based on available data • Ignores 6-month “start-up” costs and benefits • Ignores other costs and benefits • Other medical costs saved or incurred • Deaths avoided 17

Page 1 and 2: Buprenorphine Cost Effectiveness Br
Page 3 and 4: Buprenorphine Cost • Cost has bee
Page 5 and 6: Cost-effectiveness ≠ Cost saving
Page 7 and 8: Questions Policy Makers Should Ask
Page 9 and 10: Cost-effectiveness vs cost-benefit?
Page 11 and 12: Published Cost-Effectiveness Studie
Page 13 and 14: Enter In Treatment Off Drugs In Tre
Page 15: Cohort Retention In Treatment By Mo
Page 19: • David Fiellin, MD • Jared Lef

Buprenorphine Cost Effectiveness

Create successful ePaper yourself

Delete template?

Save as template?